Two experiments were carried out in the albino rat to investigate the
role of brain adrenergic systems in DNA remodeling. Adult male Sprague
-Dawley rats were given an intraventricular microinjection of an adren
ergic drug or vehicle followed 2 h later by the intraventricular injec
tion of 50 mu Ci of [H-3-methyl]thymidine. The rats were sacrificed 0.
5 h after the injection of the radioactive tracer. The rate of DNA syn
thesis was determined by measuring the amount of radioactive precursor
incorporated into the DNA extracted from homogenates of several brain
areas. In Experiment 1, at time 0 rats received the alpha-adrenergic
antagonist phentolamine (5 mu g), the beta antagonist propranolol(10 m
u g), the alpha agonist phenylephrine (1 mu g), the beta agonist isopr
oterenol (12.5 mu g), or the vehicle. The latter decreased UBDS in neo
cortex, and increased it in the septum, neostriatum, hypothalamus, cer
ebellum, and rest of the brain. The alpha and beta agonists and antago
nists induced several significant effects, depending on the brain regi
on. In Experiment 2, rats were bilaterally lesioned in the dorsal nora
drenergic bundle (DNB) by injection of 6-hydroxydopamine or were sham
lesioned. One week later, at time 0 they were given the alpha agonist
phenylephrine (1 mu g), the beta agonist isoproterenol (12.5 mu g), or
the vehicle. The DNB-lesioned rats showed a higher UBDS in the hippoc
ampus, neocortex, and hypothalamus, which was reversed by the alpha or
the beta agonist. The results suggest an influence of the DNB, probab
ly as a tonic inhibitor of UBDS in the hippocampus and the hypothalamu
s which, in turn, are likely to be mediated by beta- and alpha-adrener
gic receptors. In addition, a phasic inhibitory effect seems to be med
iated by beta and alpha receptors in the neocortex, and by beta recept
ors in the cerebellum. A modulatory role of central adrenergic systems
on unscheduled brain DNA synthesis may be inferred from these finding
s.